This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
This post briefly introduces chimeric molecules and companies working on them, contains a list of 10 recent “hot” papers in…
Article
3 years ago ●
8 mins read
Context. Pevonedistat (Takeda) is a first-in-class intravenous or subcutaneous NEDD8-activating enzyme (NAE) inhibitor being developed for leukemia and advanced solid…
molecule
10 months ago ●
5 mins read
or, How I Learned to Stop Worrying and Love My Own Definition. Recently I posted on “biologic drugs” which were…
Article
3 years ago ●
6 mins read
Context. “Compound 20” (Gedeon Richter) is an oral α5-GABAA receptor negative allosteric modulator (NAM) being developed for cognitive disorders. GABA…
molecule
10 months ago ●
4 mins read
By Michael Lambrecht We all knew process scientists were good, but the Merck and Codexis teams just took it to…
Article
3 years ago ●
5 mins read
Context. NVP-CLR457 (Novartis Institutes for BioMedical Research) is an oral, non-CNS-penetrating pan-class IA phosphoinositide 3-kinase (PI3K) inhibitor. Due to the…
molecule
10 months ago ●
6 mins read
Load More
